SOFW SOFWAVE MEDICAL LTD

Sofwave Names Larry Laber, Aesthetic Energy-Based Device Sales Veteran, to Role of Executive Vice President, North American Sales

Sofwave Names Larry Laber, Aesthetic Energy-Based Device Sales Veteran, to Role of Executive Vice President, North American Sales

SAN CLEMENTE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced the appointment of Larry Laber to the role of Executive Vice President, North American Sales. Mr. Laber is an aesthetic energy-based medical device sales veteran with more than 20 years of experience in the industry. Mr. Laber will be responsible for managing and continuing the buildout of the US sales team, and alignment of the go to market strategy with our partner in Canada, XCite medical.

Louis Scafuri, Sofwave’s Chief Executive Officer, said, “We are delighted to have someone with Larry’s extensive and proven industry track record leading Sofwave’s sales force. Throughout his career, he has increased revenue streams, built leading brands, and expanded market share. Larry’s strategic vision and consistent results have earned him a reputation as a widely recognized commercial leader in the aesthetic energy-based medical device industry.”

Mr. Laber commented, “I’m honored to join Sofwave at this exciting period of company growth. I have been following Sofwave since their entrée into the U.S. energy-based medical aesthetics market. I have been really impressed with how far along the Company has come in disrupting the industry in just a few short years since receiving FDA approval for the Sofwave console. We now have a complete and even more compelling platform to improve skin laxity, lift, and tone with the introduction of Pure Impact™ non-invasive muscle toning module to create the Sofwave Plus Pure Impact system. I could not be more enthusiastic to lead sales in North America and further advance Sofwave’s direct sales penetration in the U.S.”

Prior to joining Sofwave, Larry served as Chief Commercial Officer at Lutronic, where he was instrumental in building one of the strongest and fastest-growing aesthetic laser companies over the last five years. His strategic vision and consistent results have earned him a reputation in the industry as a proven senior commercial leader. Larry’s career is marked by his dedication to excellence and his consistent success in increasing revenue, leading commercial teams, building brands, and expanding market share. Larry holds a B.A. in Communications from California State University, Northridge, and he is passionate about building and leading dynamic teams that succeed at the highest levels.

About Sofwave Medical

 has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), lifting lax skin in the arms, as well as the short-term improvement in the appearance of cellulite and treatment of acne scars. The company’s Pure Impact™ module uses EMS technology and is cleared for muscle toning. Sofwave’s products provide physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: 

Investor Contact:

Brian Ritchie

LifeSci Advisors LLC

(212) 915-2578



EN
04/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SOFWAVE MEDICAL LTD

 PRESS RELEASE

Sofwave Medical Reports Preliminary, Unaudited, Fourth Quarter and Ful...

Sofwave Medical Reports Preliminary, Unaudited, Fourth Quarter and Full Fiscal Year 2025 Topline Financial Results SAN CLEMENTE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced preliminary financial results for the fourth quarter and full fiscal year, for the period ended December 31, 2025. Preliminary Financial Results Fourth quarter 2025 revenue is expected to total between $28.6 million and $28.9 million, as compared to approximately $1...

 PRESS RELEASE

Sofwave Medical Reports Third Quarter 2025 Financial Results and Busin...

Sofwave Medical Reports Third Quarter 2025 Financial Results and Business Highlights —  Record quarterly revenue in third quarter of $21.1M, +56% year-over-year growth; IFRS gross margin of 73.7%  — Third quarter pulse recurring revenue of $8.3M, +55% year-over-year growth — First nine months revenue of $58.7M, +42% year-over-year growth; IFRS gross margin of 75.1% — First nine months IFRS and non-IFRS net income of $1.4M and $3.2M, respectively, versus a net loss of $3.8M and $2.1M, respectively, in the same year ago period — Approximately 667,00 pulse treatments administered...

 PRESS RELEASE

Sofwave to Participate in Upcoming November Investor Conferences

Sofwave to Participate in Upcoming November Investor Conferences SAN CLEMENTE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that management will participate in the following investor conferences: Stifel 2025 Healthcare ConferencePresentation Format: Corporate overviewPresentation Date: Wednesday, November 12, 2025Presentation Time: 10:40 a.m. ETWebcast: Jefferies London Healthcare Conference Presentation Format: Corporate overviewPresentation Date: ...

 PRESS RELEASE

Sofwave to Participate in the Jefferies Virtual Private MedTech Summit

Sofwave to Participate in the Jefferies Virtual Private MedTech Summit SAN CLEMENTE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the Jefferies Virtual Private MedTech Summit on October 1st, 2025. About Sofwave Medical has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology...

 PRESS RELEASE

Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Stand...

Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Standalone EMS Device For Comprehensive Multi-Body Area Muscle Strengthening and Firming The Pure Impact VIP™ standalone device represents a major extension of the Pure Impact™ product line and introduces an all-in-one independent unitStandalone device is launched with an enhanced Pure Impact™ feature set which provides comprehensive muscle strengthening programs that focus on multiple body areas including the: abdomen, arms, thighs, and buttocks and enables simultaneous treatment of 6 muscle groupsIn the recent McKinsey Life ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch